Arthritis Research & Therapy

official impact factor 4.36

An important step towards completing the rheumatoid arthritis cycle

Walther J van Venrooij* and Ger JM Pruijn

Arthritis Research & Therapy 2008, 10:117 doi:10.1186/ar2504

Accesses  

  • Last 30 days: 38 accesses
  • Last year: 604 accesses
  • All time: 3313 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

Katleen Van Steendam, Kelly Tilleman, Marlies De Ceuleneer, Filip De Keyser, Dirk Elewaut, Dieter Deforce Arthritis Research & Therapy 2010, 12:R132 (7 July 2010)

Research article   Open Access Highly Accessed

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

Raimon Sanmartí, Eduard Graell, Maria L Perez, Guadalupe Ercilla, Odette Viñas, Jose A Gómez-Puerta, Jordi Gratacós, Alejandro Balsa, Maria J Gómara, Marta Larrosa, Juan D Cañete, Isabel Haro Arthritis Research & Therapy 2009, 11:R135 (2 September 2009)